These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 22760352

  • 21. Early response as predictor of final remission in elderly depressed patients.
    Kok RM, van Baarsen C, Nolen WA, Heeren TJ.
    Int J Geriatr Psychiatry; 2009 Nov; 24(11):1299-303. PubMed ID: 19322797
    [Abstract] [Full Text] [Related]

  • 22. [Pharmacological justification for the use of new antidepressant drugs].
    Nowakowska E, Kus K, Bobkiewicz-Kozłowska T.
    Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
    [Abstract] [Full Text] [Related]

  • 23. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR, Nemeroff CB.
    Depress Anxiety; 1998 Sep; 7 Suppl 1():24-32. PubMed ID: 9597349
    [Abstract] [Full Text] [Related]

  • 24. Antidepressants.
    Frazer A.
    J Clin Psychiatry; 1997 Sep; 58 Suppl 6():9-25. PubMed ID: 9227669
    [No Abstract] [Full Text] [Related]

  • 25. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
    Nelson JC.
    Depress Anxiety; 1998 Jul; 7 Suppl 1():5-6. PubMed ID: 9597344
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Acute reversible dyskinesia induced by mirtazapine.
    Konitsiotis S, Pappa S, Mantas C, Mavreas V.
    Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
    [No Abstract] [Full Text] [Related]

  • 32. Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.
    Jagsch C, Marksteiner J, Seiringer E, Windhager E.
    Pharmacopsychiatry; 2007 May; 40(3):129-31. PubMed ID: 17541890
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. STAR*D level IV methodology.
    Wingo AP, Ghaemi SN.
    Am J Psychiatry; 2007 Apr; 164(4):681; author reply 681. PubMed ID: 17403987
    [No Abstract] [Full Text] [Related]

  • 36. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
    Deuschle M, Gilles M, Scharnholz B, Lederbogen F, Lang UE, Hellweg R.
    Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hyperglycaemia secondary to mirtazapine therapy in a 37-year-old man.
    Chen R, Lopes J.
    Aust N Z J Psychiatry; 2008 Nov; 42(11):990-1. PubMed ID: 18946939
    [No Abstract] [Full Text] [Related]

  • 39. Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: a case report.
    Safer DL, Darcy AM, Lock J.
    Int J Eat Disord; 2011 Mar; 44(2):178-81. PubMed ID: 20127940
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.